Question follow-through · 17653
NHS: Drugs
To ask the Secretary of State for Health and Social Care, when his Department last tested contingency arrangements for maintaining the distribution of medicines on the Critical Medicines List in the event of a major disruption to a) supply chains or b) tr
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 9 Jul 2026
- Target answer date
- 13 Jul 2026
- Answer
- 16 Jul 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
9 Jul 2026
Question tabled
To ask the Secretary of State for Health and Social Care, when his Department last tested contingency arrangements for maintaining the distribution of medicines on the Critical Medicines List in the event of a major disruption to a) supply chains or b) tr
13 Jul 2026
Target answer date
Date supplied by the official written-questions record.
16 Jul 2026
Answer published
The Department's contingency plans for maintaining the supply of medical products are under ongoing review by the Cabinet Office through their National Capabilities Assessment. This tests the Department's response to scenarios on the National Risk Registe...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.